Plasma proteomic profiles for early detection and risk stratification of non‐small cell lung carcinoma: A prospective cohort study with 52,913 participants
International Journal of Cancer · 2025
DOI: 10.1002/ijc.35518 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Renjia Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Genetics and Development of Complex Phenotypes, Human Phenome Institute, Zhangjiang Fudan International Innovation Center, Fu…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Proteomics, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Shanghai Municipal Science and Technology Major Project.
Abstract (Originalsprache)
Early detection of non‐small cell lung cancer (NSCLC) can improve survival rates, and plasma proteomics may provide effective tools for risk prediction. The population for this study included 52,913 participants and 2911 plasma proteomics from UK Biobank. The cohort was divided into discovery and validation cohorts based on their countries. Cox regression, XGBoost, and SHAP analysis were used to identify key NSCLC‐associated proteins. Machine learning (ML) models were developed and validated across different timeframes. Risk stratification was performed using protein levels. Temporal change analysis and two‐sample Mendelian Randomization (MR) were conducted to assess the early prediction ability and causal relationships, respectively. Twenty‐five proteins were significantly associated with NSCLC. ML identified CXCL17, CEACAM5, and WFDC2 as having the highest predictive power. The three‐protein panel plus epidemiological indicators exhibited superior performance in 5‐ and 10‐year predictions, achieving AUROC of 0.904 (95%CI: 0.839–0.968) and 0.873 (95%CI: 0.815–0.931), respectively. Risk stratification identified a high‐risk group with a 9.18‐fold higher risk than the general population and a 16.75‐fold higher risk than the low‐risk group, respectively. Temporal change analysis revealed that protein expression levels in cases were globally higher than in controls up to 10 years before diagnosis. MR implied a suggestive causal relationship between CXCL17 and NSCLC. Our findings suggest three plasma proteins possess robust predictive capabilities for NSCLC, allowing for predictions up to 10 years in advance. Incorporating these biomarkers into risk models enhances early detection, providing a foundation for targeted screening and precision medicine in NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Genetics and Development of Complex Phenotypes, Human Phenome Institute, Zhangjiang Fudan International Innovation Center, Fudan University, Shanghai, China.
- Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
- Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China.
- Department of Biostatistics, School of Public Health, Fudan University, Shanghai, China.
- Fudan University Taizhou Institute of Health Sciences, Taizhou, Jiangsu, China.
- Shanghai Institute of Infectious Disease and Biosecurity, Shanghai, China.
ORCID-Profile: Renjia Zhao, Chen Suo, Xingdong Chen
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Shanghai Municipal Science and Technology Major Project
Zitieren
APA
Zhao, R., Lu, H., Yuan, H., Chen, S., Xu, K., Zhang, T., Liu, Z., Jiang, Y., Suo, C., & Chen, X. (2025). Plasma proteomic profiles for early detection and risk stratification of non‐small cell lung carcinoma: A prospective cohort study with 52,913 participants. International Journal of Cancer. https://doi.org/10.1002/ijc.35518
Vancouver
Zhao R, Lu H, Yuan H, Chen S, Xu K, Zhang T, et al. Plasma proteomic profiles for early detection and risk stratification of non‐small cell lung carcinoma: A prospective cohort study with 52,913 participants. International Journal of Cancer. 2025. doi:10.1002/ijc.35518
BibTeX
@article{Zhao2025,
author = {Zhao, Renjia and Lu, Heyang and Yuan, Huangbo and Chen, Shuaizhou and Xu, Kelin and Zhang, Tiejun and Liu, Zhenqiu and Jiang, Yanfeng and Suo, Chen and Chen, Xingdong},
title = {Plasma proteomic profiles for early detection and risk stratification of non‐small cell lung carcinoma: A prospective cohort study with 52,913 participants},
journal = {International Journal of Cancer},
year = {2025},
doi = {10.1002/ijc.35518}
}
EUVIMED